Sabinsa showcased its lineup of top-selling ingredients at the recently concluded Bio-Asia Taiwan 2024 event in Taipei, a premier exhibition focused on demonstrating breakthrough advancements and fostering collaboration within the biomedical and pharmaceutical sectors.

At the show, Sabinsa highlighted its clinically validated products, including:

• Curcumin C³ Complex™ from Curcuma longa, standardized for a minimum of 95% Curcuminoids.
• BioPerine™, a natural bioavailability enhancer, standardized for minimum 95% Piperine.
• LactoSpore®, Weizmannia coagulans MTCC 5856, an shelf-stable probiotic.
• Saberry™, a multifaceted phytonutrient from Amla fruit standardized to contain 10% β-glucogallin.
• ForsLean® from Coleus forskohlii, standardized to contain 10 % forskolin.

Other breakthrough products that were on display at the expo include Boswellin™ (to support joint health and mobility); Sabeet™ (to promote sports performance); GS4 PLUS™ (for healthy blood sugar management); and Ginger Dry Extract and Pomegranate Extract (for general health).

Mr. Shaheen Majeed, Sabinsa Global CEO & Managing Director, stated, "We are energized to see customers interest in our products at the expo. Taiwan is a promising market for Sabinsa, and we are progressively diversifying our product range in the dietary supplement and functional food categories here.”

Trademark of Sabinsa:
BioPerine™, Boswellin™, Curcumin C³ Complex™ , ForsLean®, GS₄ PLUS™, LactoSpore®, Nigellin™, Sabeet™, and Saberry™